Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes
Authors:
- 26 June 2009
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 11 (8) , 819-822
Abstract
Aim: Type 2 diabetes is characterized by hyperglycaemia, delayed gastric emptying and a blunted response of gut hormones during feeding that may modulate satiety. We hypothesized that it is associated with more hunger when treated by medication. Methods: We studied nine type 2 diabetic men (A1C: 6.7 ± 0.3%, waist circumference: 104 ± 4 cm) after an overnight fast, during 5 h in response to a 2.88 MJ breakfast, twice, in a crossover design, with or without antihyperglycaemic agents. Satiety ratings, thermic effect of meal, gastric emptying, plasma concentrations of gut peptides, leptin, insulin and substrates and intake from a subsequent buffet were determined. Results: With medication, fasting and postprandial plasma glucose levels were lower but area under the curve (AUC) did not vary vs. without medication. Gastric emptying was shortened, branched chain amino acids (BCAA) AUC and thermic effect were lower, and postprandial glucagon‐like peptide‐1 (GLP‐1) and peptide tyrosine tyrosine (PYY 3–36 ) were maintained at higher levels beyond 4 h. Correlations were significant between duration of diabetes and fasting ghrelin (r = 0.779, p = 0.013) and peak insulin (r = −0.769, p = 0.016), 5‐h postmeal ghrelin and peak glucose (r = 0.822, p = 0.007), 5‐h glucose and GLP‐1 (r = −0.788, p = 0.012), and 5‐h hunger scores and energy intake at buffet (r = 0.828, p = 0.006). Without medication, fullness scores correlated with BCAA levels. Visual analogue scale scores, ghrelin and leptin levels did not differ between studies. Conclusions: The decrease in factors associated with postprandial satiety with treatment is counterbalanced by higher GLP‐1 and PYY 3–36 . Medication may normalize the link between perception of hunger and subsequent food intake.Keywords
This publication has 11 references indexed in Scilit:
- Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetesDiabetes/Metabolism Research and Reviews, 2006
- Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamberThe American Journal of Clinical Nutrition, 2006
- Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced SatietyEndocrinology, 2006
- Modulation of Food Intake by Glucose in Patients With Type 2 DiabetesDiabetes Care, 2005
- Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitusDiabetologia, 2005
- Prevalence of Delayed Gastric Emptying in Diabetic Patients and Relationship to Dyspeptic SymptomsDiabetes Care, 2003
- The Gut Hormone Peptide YY Regulates AppetiteAnnals of the New York Academy of Sciences, 2003
- Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 2003
- A paracetamol‐pasta test for assessing gastric emptying in healthy and diabetic subjectsScandinavian Journal of Clinical and Laboratory Investigation, 2003
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000